Unraveling the Role of Endothelial Dysfunction in Osteonecrosis of the Femoral Head: A Pathway to New Therapies
Open Access
- 15 March 2024
- journal article
- review article
- Published by MDPI AG in Biomedicines
- Vol. 12 (3) , 664
Abstract
Osteonecrosis of the femoral head (ONFH) is a disabling disease characterized by the disruption of the blood supply to the femoral head, leading to the apoptosis and necrosis of bone cells and subsequent joint collapse. Total hip arthroplasty is not optimal since most patients are young. Multiple risk factors contribute to osteonecrosis, including glucocorticoid (GC) usage, excessive alcohol intake, hypercholesterolemia, and smoking. Continuous stimulation by many variables causes a chronic inflammatory milieu, with clinical repercussions including endothelial dysfunction, leading to thrombosis, coagulopathy, and poor angiogenesis. Immune cells are the primary regulators of inflammation. Innate and adaptive immune cells interact with endothelial cells to hinder the regeneration and repair of bone lesions. An in-depth examination of the pathological drivers of ONFH reveals that endothelial dysfunction may be a major cause of osteonecrosis. Understanding the involvement of endothelial dysfunction in the chronic inflammation of osteonecrosis could aid in the development of possible therapies. This review summarizes the role of endothelial cells in osteonecrosis and further explains the pathophysiological mechanism of endothelial dysfunction in this disease from the perspective of inflammation to provide new ideas for the treatment of osteonecrosis.Keywords
Funding Information
- National Natural Science Foundation of China (82102627, 82270935, 81974337, 2021CFB095, 2022020801020468, WX21Q19)
- Hubei Provincial Natural Science Foundation of China (82102627, 82270935, 81974337, 2021CFB095, 2022020801020468, WX21Q19)
- Wuhan Knowledge Innovation Project (82102627, 82270935, 81974337, 2021CFB095, 2022020801020468, WX21Q19)
- Project of Scientific Research Plan of Wuhan Municipal Health Commission (82102627, 82270935, 81974337, 2021CFB095, 2022020801020468, WX21Q19)
This publication has 146 references indexed in Scilit:
- Endothelial Cell‐Derived Lactate Triggers Bone Mesenchymal Stem Cell Histone Lactylation to Attenuate OsteoporosisAdvanced Science, 2023
- Neutrophil, neutrophil extracellular traps and endothelial cell dysfunction in sepsisClinical and Translational Medicine, 2023
- Targeting the Microenvironment of Vulnerable Atherosclerotic Plaques: An Emerging Diagnosis and Therapy Strategy for AtherosclerosisAdvanced Materials, 2022
- Glucocorticoid‐induced osteonecrosis in systemic lupus erythematosus patientsClinical and Translational Medicine, 2021
- Reduced phagocytosis, ROS production and enhanced apoptosis of leukocytes upon alcohol drinking in healthy volunteersEuropean Journal of Trauma and Emergency Surgery, 2021
- Glucocorticoids induce femoral head necrosis in rats through the ROS/JNK/c‐Jun pathwayFEBS Open Bio, 2020
- Desferoxamine protects against glucocorticoid‐induced osteonecrosis of the femoral head via activating HIF‐1α expressionJournal of Cellular Physiology, 2020
- Coupling factors involved in preserving bone balanceCellular and Molecular Life Sciences, 2018
- Neutrophil Extracellular Trap–Derived Enzymes Oxidize High‐Density Lipoprotein: An Additional Proatherogenic Mechanism in Systemic Lupus ErythematosusArthritis & Rheumatology, 2014
- Cell-based immunotherapy with mesenchymal stem cells cures bisphosphonate-related osteonecrosis of the jaw–like disease in miceJournal of Bone and Mineral Research, 2010